Back to School: How biopharma can reboot drug development. Access exclusive analysis here

EC approves Eli Lilly's Yentreve

The EC granted European marketing approval to LLY and partner Boehringer Ingelheim (Ridgefield, Conn.)

Read the full 145 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE